Background
==========

*Klebsiella pneumoniae* liver abscess (KPLA) has been reported with increasing frequency in East Asian countries in the past 3 decades, especially in Taiwan and Korea \[[@B1]-[@B7]\]. *K*. *pneumoniae* is the dominant cause of pyogenic liver abscesses in Taiwan and has contributed to the endemic feature of the disease in Taiwan \[[@B8]-[@B10]\]. Since 1986, many researchers in Taiwan and several other areas have noted the distinctive syndrome of KPLA, complicated by bacteremia, sepsis, and metastatic infection of brain, eyes, lungs and other organs, especially in patients with diabetes \[[@B2],[@B5],[@B6],[@B11]-[@B15]\]. The mortality rate of KPLA has decreased in recent years in Taiwan \[[@B6],[@B8]\]; nevertheless, despite aggressive therapy, the outcomes of these patients frequently involve catastrophic disability. Our recent study also has indicated that catastrophic disability due to ocular or neurological complications from KPLA could lead to poor long-term prognosis \[[@B10]\].

Patients with diabetes are at increased risk for common infection due to impaired host defense mechanisms \[[@B16]\]. Diabetes is a well-known risk factor for pyogenic liver abscess \[[@B17]\] and highly associated with KPLA \[[@B5],[@B18],[@B19]\]. One animal study of KPLA has suggested that diabetes might provide a specialized environment that allows *K*. *pneumoniae* strains to disseminate from the intestines into the blood \[[@B20]\]. In addition, diabetes is the most common underlying disease among patients with septic metastatic complications from KPLA \[[@B12],[@B13],[@B19],[@B21]\], and predisposes patients with KPLA to develop septic metastasis \[[@B22]\]. Compared with the monomicrobial cryptogenic noninvasive KPLA, cryptogenic KPLA with septic metastasis is characterized by an \~20-fold increased association with diabetes \[[@B23]\].

Previous studies have compared the characteristics of liver abscess patients with and without diabetes \[[@B17],[@B18],[@B24]\]. The influence of diabetes on KPLA has also been described \[[@B1]\]. However, no research is available on the impact of glycemic control on the characteristics of KPLA in diabetic patients. To monitor glycemic control, hemoglobin A1c (HbA~1c~) gives an estimate of average blood glucose during the preceding 3 months, and is widely accepted as the primary indicator of the level of glycemic control for optimal management of diabetes \[[@B25]\].

Therefore, we conducted this study to investigate whether glycemic control assessed by HbA~1c~ affected the clinical characteristics of diabetic patients with KPLA.

Methods
=======

Study design, patient populations, and data collection
------------------------------------------------------

This study was a retrospective cohort analysis of consecutive diabetic patients with KPLA at Taipei Veterans General Hospital, a tertiary medical center with a 2900-bed capacity. Those patients with KPLA were identified by reviewing culture records from the Department of Microbiology from January 2007 to January 2012. We excluded patients aged \< 20 years. Age, sex, underlying diseases, clinical presentations, laboratory findings, including images, and management were collected. Assessment of blood glucose control was based on HbA~1c~ levels at the time of infection or as close to the time of infection as possible, within one month before this episode of KPLA. The major outcome measurements included intensive care unit admission within 48 hours, length of hospitalization, and mortality. Septic metastatic infection is highly associated with diabetic patients with KPLA; therefore, we analyzed the risk factors among these patients. This study was approved by Institutional Review Board of Taipei Veterans General Hospital.

Definitions
-----------

An episode of KPLA was defined as the presence of ≥ 1 liver abscess, detected by sonography or computed tomography, and culture-confirmed *K*. *pneumoniae* isolated from an abscess or blood. Only the first episode of KPLA in a particular patient, diagnosed at our hospital during the period of study, was included. For the diagnosis of diabetes, the American Diabetes Association diagnostic criteria were used \[[@B25]\]. Patients with diabetes were defined as those with a history of either type 1 or type 2 diabetes and/or those taking either insulin and/or oral hypoglycemic agents. If diabetes was diagnosed during the patient's treatment for this episode of KPLA, newly diagnosed diabetes was recorded. Chronic kidney disease was indicated by a creatinine level ≥ 2.0 mg/dL. Chronic lung disease was defined as chronic obstructive pulmonary diseases, bronchiectasis, or any structural lung diseases with the exception of bronchogenic carcinoma. Cryptogenic origin of infection was defined as that in which no obvious extrahepatic source of infection could be identified \[[@B22]\]; biliary tract origin was defined if clinical features of cholecystitis/cholangitis or extrahepatic biliary ductal abnormalities were identified on radiographic images. Multiple abscesses mean \>; 2 abscess in liver parenchyma confirmed by imaging. Metastatic infection was defined as a distant site of infection isolated with the same pathogen as the pyogenic liver abscess (*K*. *pneumoniae*).

Microbiology laboratory procedures
----------------------------------

The VITEK 2 system (bioMérieux, Marcy l\'Etoile, France) was used to confirm bacterial identifications among the available isolates. *magA* is the serotype K1 wzy allele and was determined among the *K*. *pneumonaie* isolates as described previously \[[@B6]\].

Statistical analysis
--------------------

We performed a 2-tailed χ^2^ test or Fisher's exact test (for contingency data) and Student's *t* test or ANOVA method (for continuous data) to compare the groups with different HbA~1c~ levels. A *P* value \< 0.05 was considered statistically significant; all probabilities were 2-tailed. Cochran-Mantel-Haenszel test with median age as the stratum was used to analyze the association between glycemic control and other factors. To identify possible independent predictors for metastatic infection, multivariate analysis was undertaken using logistic regression to adjust for the presence of confounding variables. Age, sex and all potential predictors with *p* ≦ 0.1 on univariate analysis were considered for inclusion in the multivariate model. All statistical analyses were performed with SPSS version 17.0 for Windows.

Results
=======

Comparison of clinical characteristics of KPLA in diabetic patients with controlled or uncontrolled glycemia
------------------------------------------------------------------------------------------------------------

During the study period, 108 diabetic patients from all of the 221 KPLA cases were identified. We excluded six patients due to lack of HbA~1c~. The remaining 102 patients all had type 2 diabetes. HbA~1c~ level \< 7% is generally considered as the target of glycemic control for diabetic patients \[[@B25],[@B26]\]. We compared patients with controlled glycemia (HbA~1c~ \< 7%) and uncontrolled glycemia (HbA~1c~ ≥ 7%). The level of HbA~1c~ in the group with uncontrolled glycemia was significantly higher than that in the group with controlled glycemia (10.0 ± 2.1 vs 6.5 ± 0.3%, *p* \< 0.001).

Table [1](#T1){ref-type="table"} showed the clinical features between these two groups. Patients with uncontrolled glycemia were younger (62.8 ± 14.9 vs 70.6 ± 9.6 years, *p* = 0.017) than those with controlled glycemia. Patients with poor glycemic control had the trend to have a higher rate of cryptogenic liver abscess (92.8 vs 78. 9%, *p* = 0.087), gas-forming liver abscess (14.5 vs 0%, *p* = 0.116), and metastatic infection (14.5 vs 0%, *p* = 0.116) than those with controlled glycemia. The underlying disease did not differ between the two groups. Most of the lesions were located in the right lobe, but the characteristics of abscess did not differ significantly between the two groups. No mortality was identified in the group with controlled glycemia. The treatment strategy did not differ among the groups with different HbA~1c~ levels. Length of stay in hospital and intensive care unit admission rate did not differ significantly between the two groups. As the age is significantly different between the groups, we compared all the characteristics after adjustment with age, which showed the consistent results. Only 41 isolates of *K*. *pneumonaie* were available for microbiological analysis, and we found that 21 isolates were positive for *magA*. The distribution of *magA* in *K*. *pneumoniae* isolates did not differ between controlled and uncontrolled groups (66.7% vs 46.9%, *p* = 0.454).

###### 

Baseline characteristics, clinical presentation, and outcome of diabetic patients with controlled or uncontrolled glycemia

                                   **Controlled glycemia (n = 19)**   **Uncontrolled glycemia (n = 83)**   ***p*value**   ***p*value, (adjusted age)**
  -------------------------------- ---------------------------------- ------------------------------------ -------------- ------------------------------
  Male                             12 (63.2)                          59 (71.1)                            0.498          0.952
  Age in years                     70.6 ± 9.6                         62.8 ± 14.9                          0.017           
  Underlying diseases                                                                                                      
   Malignancy                      1 (5.6)                            10 (12.7)                            0.683          0.367
   Alcoholism                      1 (5.3)                            4 (4.8)                              1.000          0.655
   Chronic kidney disease          1 (5.6)                            8 (10.3)                             1.000          0.311
   Liver cirrhosis                 0 (0)                              2 (2.4)                              1.000          0.494
   Congestive heart failure        0 (0)                              2 (2.4)                              1.000          0.392
   Chronic lung disease            0 (0)                              1 (1.2)                              1.000          0.549
  Newly diagnosed diabetes         4 (21.1)                           21 (25.3)                            1.000          0.995
  Origin                                                                                                                   
   Cryptogenic                     15 (78.9)                          77 (92.8)                            0.087          0.090
   Biliary tract origin            1 (5.3)                            5 (6.0)                              1.000          0.785
  Abscess locations                                                                                                        
   Right lobe                      11 (57.9)                          44 (53.0)                            0.791          0.407
   Left lobe                       5 (26.3)                           19 (22.9)                                            
   Both lobes                      3 (15.8)                           20 (24.1)                                            
  Abscess size                                                                                                            
   \< 5 cm                         9 (47.4)                           36 (43.4)                            1.000          0.707
   5 \~ 10 cm                      9 (47.4)                           39 (47.0)                                            
   \>; 10 cm                       1 (5.3)                            8 (9.6)                                              
  Gas forming                      0 (0)                              12 (14.5)                            0.116          0.126
  Multiple abscesses               8 (42.1)                           29 (34.9)                            0.558          0.791
  Initial laboratory value                                                                                                 
   Leukocyte count, × 10^3^/μL     12.4 ± 3.8                         13.5 ± 6.0                           0.165          0.417
   Platelet, × 10^3^/μL            195 ± 87                           229 ± 121                            0.145          0.442
   C-reactive protein, mg/dL       18.8 ± 9.2                         20.0 ± 9.8                           0.487          0.779
   Glucose, mg/dL                  193 ± 76                           318 ± 168                            0.007          0.004
  Treatment                                                                                                                
   Antibiotics + drainage          16 (84.2)                          69 (83.1)                            1.000          0.894
   Antibiotics + operation         1 (5.3)                            3 (3.6)                              0.568          0.525
   Antibiotics only                2 (10.5)                           11 (13.4)                            1.000          0.557
  Metastatic infections            0 (0)                              12 (14.5)                            0.116          0.077
  Outcome                                                                                                                  
   Hospitalization days            26.2 ± 12.1                        28.1 ± 19.0                          0.692          0.428
   Intensive care unit admission   2 (10.5)                           12 (14.5)                            1.000          0.849
   Mortality                       0 (0)                              3 (3.6)                              1.000          0.359

Data are presented as mean ± SD or frequency with percentage (%).

Comparison of clinical characteristics in KPLA diabetic patients according to different HbA~1c~ levels
------------------------------------------------------------------------------------------------------

To analyze further the impact of glycemic control on the clinical characteristics of KPLA, we divided the patients into three groups according to HbA~1c~ level: \< 7%, 7--10% and \>; 10%, as shown in Table [2](#T2){ref-type="table"}. A HbA~1c~ level \>; 10% suggested poorly controlled diabetes \[[@B25]\]. The level of HbA~1c~ was significantly different in the three groups (6.5 ± 0.3 vs 8.4 ± 0.9 vs 11.8 ± 1.6%, *p* \< 0.001). Patients with HbA~1c~ \>; 10% were significantly younger (*p* \< 0.001) than the other two groups. Newly diagnosed diabetes, cryptogenic origin abscess, and metastatic infection were more common in the group of HbA~1c~ level \>; 10%. Cryptogenic origin abscess and metastatic infection were still more common in the group of HbA~1c~ level \>; 10% after adjustment with age.

###### 

**Baseline characteristics, clinical presentation, and outcome of diabetic patients with KPLA according to different HbA**~**1c**~**levels**

  **Factor**                     **HbA**~**1c**~** \< 7% (n = 19)**   **HbA**~**1c**~**= 7 \~ 10% (n = 44)**   **HbA**~**1c**~** \>; 10% (n = 39)**   ***p*value**   ***p*value, (adjusted age)**
  ------------------------------ ------------------------------------ ---------------------------------------- -------------------------------------- -------------- ------------------------------
  Male                           12 (63.2)                            30 (68.2)                                29 (74.4)                              0.660          0.999
  Age in years                   71.3 ± 9.9                           68.2 ± 11.4                              56.3 ±15.8                             \<0.001         
  Underlying diseases                                                                                                                                                 
   Malignancy                    1 (5.6)                              8 (20.0)                                 2 (5.1)                                0.100          0.560
   Alcoholism                    1 (5.3)                              0 (0)                                    4 (10.3)                               0.081          0.378
   Chronic kidney disease        1 (5.6)                              7 (17.5)                                 1 (2.6)                                0.067          0.889
   Liver cirrhosis               0 (0)                                2 (4.5)                                  0 (0)                                  0.667          0.676
   Congestive heart failure      0 (0)                                2 (4.5)                                  0 (0)                                  0.667          0.970
   Chronic lung disease          0 (0)                                1 (2.3)                                  0 (0)                                  1.000          0.979
  Newly diagnosed diabetes       4 (21.1)                             6 (13.6)                                 15 (38.5)                              0.028          0.146
  Origin                                                                                                                                                              
   Cryptogenic                   15 (78.9)                            38 (86.4)                                39 (100.0)                             0.008          0.008
   Biliary tract origin          1 (5.3)                              5 (11.4)                                 0 (0)                                  0.068          0.287
  Abscess locations                                                                                                                                                   
   Right lobe                    11 (57.9)                            23 (52.3)                                21 (53.8)                              0.442          0.214
   Left lobe                     5 (26.3)                             13 (29.5)                                6 (15.4)                                               
   Both lobes                    3 (15.8)                             8 (18.2)                                 12 (30.8)                                              
  Abscess size                                                                                                                                                       
   \< 5 cm                       9 (47.4)                             18 (40.9)                                18 (46.2)                              0.962          0.829
   5 \~ 10 cm                    9 (47.4)                             21 (47.7)                                18 (46.2)                                              
   \>; 10 cm                     1 (5.3)                              5 (11.4)                                 3 (7.7)                                                
  Gas forming                    0 (0)                                6 (13.6)                                 6 (15.4)                               0.218          0.317
  Multiple abscesses             8 (42.1)                             12 (27.3)                                17 (43.6)                              0.256          0.308
  Initial laboratory value                                                                                                                                            
   Leukocyte count, × 10^3^/μL   12.4 ± 3.8                           14.4 ± 5.6                               12.4 ± 6.2                             0.168          0.225
   Platelet, × 10^3^/μL          195 ± 87                             222 ± 102                                237 ± 140                              0.380          0.734
   C-reactive protein, mg/dL     18.8 ± 9.2                           19.3 ± 9.6                               20.9 ± 10.1                            0.539          0.826
   Glucose, mg/dL                193 ± 76                             270 ± 152                                371 ± 170                              \<0.001        \<0.001
  Treatment                                                                                                                                                           
   Antibiotics + drainage        16 (84.2)                            37 (84.1)                                32 (82.1)                              1.000          0.779
   Antibiotics + operation       1 (5.3)                              2 (4.5)                                  1 (2.6)                                1.000          0.345
   Antibiotics only              2 (10.5)                             6 (13.6)                                 5 (13.2)                               1.000          0.524
  Metastatic infections,         0 (0)                                3 (6.8)                                  9 (23.1)                               0.021          0.004
  Outcome                                                                                                                                                             
   Hospitalization days          26.3 ± 15.7                          31.9 ± 23.2                              24.9 ± 12.5                            0.201          0.265
   ICU admission                 2 (10.5)                             5 (11.4)                                 7 (17.9)                               0.695          0.605
   Mortality                     0 (0)                                1 (2.3)                                  2 (5.1)                                0.785          0.181

Data are presented as mean ± SD or frequency with percentage (%).

Risk factors for metastatic infections from KPLA in diabetic patients
---------------------------------------------------------------------

The rate of metastatic infection was 11.8% in diabetic KPLA (n = 12), and the commonest infectious site was the eyes (n = 3) and lungs (n = 3), followed by the spleen (n = 2), kidneys (n = 2), prostate (n = 1), and muscle over the left thigh (n = 1). Two patients with metastatic infection died and the mortality rate was significantly higher than that without metastatic infection (16.7 vs 1.1%, *p* = 0.036). Table [3](#T3){ref-type="table"} showed the risk factors metastatic infection from KPLA. Logistic regression analysis revealed that HbA~1c~ level (odds ratio \[OR\], 1.50; 95% confidence interval \[CI\], 1.01-2.25; *p* = 0.047) abscess size \< 5 cm (OR, 4.72; 95% CI, 1.09--20.52; *p* = 0.038) were the independent predictors of metastatic infection.

###### 

Risk factors for metastatic infection of KPLA in diabetic patients

                                    **No metastatic infection (n = 90)**   **Metastatic infection (n = 12)**   **Univariate analysis**   **Multivariate analysis**   
  --------------------------------- -------------------------------------- ----------------------------------- ------------------------- --------------------------- -------
  Male                              63 (70.0)                              8 (66.7)                            0.814                     0.76 (0.16--3.59)           0.733
  Age in years                      64.4 ± 14.2                            63.2 ± 16.0                         0.779                     1.02 (0.97--1.08)           0.430
  Underlying diseases                                                                                                                                                 
   Malignancy                       10 (11.8)                              1 (8.3)                             0.772                     --                          --
   Alcoholism                       4 (4.8)                                1 (8.3)                             0.564                     --                          --
   Chronic kidney disease           9 (10.6)                               0 (0)                               0.999                     --                          --
   Liver cirrhosis                  2 (2.2)                                0 (0)                               0.999                     --                          --
   Congestive heart failure         2 (2.2)                                0 (0)                               0.999                     --                          --
   Chronic lung disease             1 (1.1)                                0 (0)                               1.000                     --                          --
  Newly diagnosed diabetes          21 (23.3)                              4 (33.3)                            0.453                     --                          --
  HbA~1c~                           9.1 ± 2.3                              11.0 ± 2.3                          0.015                     1.50 (1.01--2.25)           0.047
  Cryptogenic origin                80 (88.9)                              12 (100)                            0.999                     --                          --
  Abscess locations in both lobes   18 (20.0)                              5 (41.7)                            0.102                     1.48 (0.29--7.60)           0.646
  Abscess size \< 5 cm              36 (40)                                9 (75)                              0.032                     4.72 (1.09--20.52)          0.038
  Gas forming                       11 (12.2)                              1 (8.3)                             0.693                     --                          --
  Multiple abscesses                29 (32.2)                              8 (66.7)                            0.028                     3.03 (0.62--14.74)          0.170
  Initial laboratory value                                                                                                                                            
   Leucocyte count, × 10^3^/μL      13.2 ± 5.5                             13.9 ± 6.8                          0.653                     --                          --
   Platelet, × 10^3^/μL             225 ± 117                              209 ± 113                           0.654                     --                          --
   C-reactive protein, mg/dL        19.5 ± 9.6                             22.3 ± 9.6                          0.339                     --                          --
   Glucose, mg/dL                   284 ± 150                              380 ± 229                           0.071                     1.00 (0.99--1.00)           0.728

Data are presented as mean ± SD orf frequency with percentage (%).

Discussion
==========

It is believed that several aspects of immunity are altered in patients with diabetes. For example, polymorphonuclear leukocyte function is depressed; leukocyte adherence, chemotaxis and phagocytosis may be affected; and antioxidant systems involved in bactericidal activity may also be impaired. Although these *in vitro* findings have not yet been fully confirmed in clinical studies, there is evidence that improving glycemic control in patients improves immune function \[[@B27]\]. Kornum et al. found that an elevated HbA~1c~ predicted increased risk for all-cause community-acquired pneumonia among patients with diabetes \[[@B28]\]. In diabetic patients with sepsis, one study has demonstrated that HbA~1c~ is an independent prognostic factor for hospital mortality and length of stay \[[@B29]\]. Regarding the issue of glycemic control and KPLA, only one case series from Taiwan analyzing 6 cases of recurrent KPLA has been reported in the literature. Five of the six patients had diabetes with poor glycemic control, and four had HbA~1c~ \>; 9% (range: 9.2--17.5%) \[[@B30]\]. The current study is, to the best of our knowledge, the first to investigate the effect of glycemic control on characteristics of KPLA in diabetic patients.

In our study, we found that patients with uncontrolled glycemia tended to be younger, and had the trend to have a higher rate of cryptogenic liver abscess, gas-forming liver abscess, and metastatic infection than those with controlled glycemia, although these differences did not reach significance. Young age, newly diagnosed diabetes, cryptogenic liver abscess and metastatic infection were more common in the poor glycemic control group (HbA~1c~ value \>; 10%). Cryptogenic invasive KPLA is frequently associated with diabetes \[[@B23]\]; therefore, we further established that it was highly linked to diabetic patients with high level of HbA~1c~. The finding that younger patients with KPLA are prone to have uncontrolled glycemia has never been reported, in part due to the small sample sizes of studies reported in the literature \[[@B6],[@B13]\].

Lin et al. have analyzed the effect of glycemic control of type 2 diabetes on neutrophil phagocytosis of serotype K1/K2 *K*. *pneumoniae* isolates. This *in vitro* study suggests that strict metabolic control may improve the neutrophil phagocytosis of K1/K2 *K*. *pneumoniae* in patients with type 2 diabetes \[[@B31]\]. In the current study focusing on diabetic patients, we not only found that the rate of metastatic infection was more common in patients with poor glycemic control, but also that HbA~1c~ level was an independent risk factor for metastatic infection. It is also notable that there was no mortality, metastatic infection or gas-forming abscess in the group with controlled glycemia. The previous *in vitro* study by Lin et al. may support our clinical findings, and we suggest that HbA~1c~ level is detrimental in KPLA, and controlled glycemia may prevent the development of serious metastatic complications.

Previous case reports have demonstrated that diagnosis of diabetes may come to light because of KPLA \[[@B32],[@B33]\]. It is notable that around 25% of cases were newly recognized diabetes in the current study despite improvement in diagnosis and awareness in recent years, and the existence of a comprehensive national health insurance program in Taiwan that optimizes access to medical care. Due to unrecognized diabetes complicated with infection, extreme hyperglycemia, even hyperglycemic hyperosmolar state or diabetic ketoacidosis, may occur. Physicians should not ignore the underlying diabetes in patients with KPLA in clinical practice. One particularly interesting finding in our study was that liver abscess \< 5 cm in diabetic patients was independently associated with metastatic infection, which has not been reported in the literature. It suggested that we should not overlook the risk of complication from small sized liver abscess in diabetic patients.

We acknowledge some limitations in our study that deserve mention. First, the data were collected retrospectively from medical records. Second, participants were recruited from a medical center in Northern Taiwan, and therefore we could not evaluate possible regional variations. Further analyses should be conducted in other regions and countries to confirm our findings. Thirdly, our results were also limited by the incomplete collection of HbA~1c~ data. Finally, the isolates were not collected for further analysis, such as virulence factors or clonal types, in the current study. Despite these limitations, our study is believed to be the first to discuss the characteristics of KPLA due to the different level of glycemic control, which sheds further light on the association between diabetes and KPLA, and our results may partly elucidate the role of host factors in the pathogenesis of KPLA.

Conclusion
==========

Patients with uncontrolled glycemia were significantly younger than those with controlled glycemia. Patients with uncontrolled glycemia had the trend to have a higher rate of gas-forming liver abscess, cryptogenic liver abscess and metastatic infection than those with controlled glycemia. Cryptogenic liver abscess and metastatic infection were more common in the poor glycemic control group (HbA~1c~ value \>; 10%). HbA~1c~ level and abscess \< 5 cm were independent risk factors for metastatic complications from KPLA. Therefore, glycemic control in diabetic patients plays an essential role in the clinical features of KPLA, especially in metastatic complications from KPLA.
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